This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bono, P. Articles by Salmi, M. Search for Related Content PubMed PubMed Citation Articles by Bono, P. Articles by Salmi, M.

(American Journal of Pathology. 1999;155:1613-1624.)
© 1999 American Society for Investigative Pathology

Regular Articles

Mouse Vascular Adhesion Protein 1 Is a Sialoglycoprotein with Enzymatic Activity and Is Induced in Diabetic Insulitis

From MediCity Research Laboratories, University of Turku, and the National Public Health Institute, Turku, Finland

The continuous recirculation of lymphocytes requires an adequate expression and function of the molecules mediating the cellular interactions between endothelium and lymphocytes. Human vascular adhesion protein 1 (hVAP-1) is an endothelial cell adhesion molecule that mediates the binding of lymphocytes to venules in peripheral lymph nodes as well as at sites of inflammation. Recently the mouse homologue of hVAP-1 has been cloned. It is a previously unknown molecule with a significant sequence identity to copper-containing amine oxidases. Besides the sequence, very little is known about the expression, structure, and function of mouse VAP-1 (mVAP-1). In this study we demonstrate that mVAP-1 is prominently expressed in endothelial and smooth muscle (but not in other types of muscle cells), as well as in adipocytes. mVAP-1 is a 220-kd homodimeric sialoglycoprotein that displays cell-type-specific differences in glycosylation. The expression of mVAP-1 is induced on inflammation in the vessels of the endocrine pancreas during the development of insulitis, and the up-regulation correlates with the extent of the lymphocytic infiltrate. In general, different mouse strains displayed very similar VAP-1 expression, but the small differences seen in liver and gut suggest that immunostimulation may modulate VAP-1 synthesis in extrapancreatic organs as well. Finally, we show that mVAP-1 has a monoamine oxidase activity against naturally occurring substrates, implying a role in the development of vasculopathies. These data show that mVAP-1 and hVAP-1 are very similar molecules that nevertheless have certain marked differences in expression, biochemical structure, and substrate specificity. Thus mVAP-1 is a novel inflammation-inducible mouse molecule that has a dual adhesive and enzymatic function.

This article has been cited by other articles:

				S. Jalkanen and M. Salmi VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 18 - 26. [Abstract] [Full Text] [PDF]

				M. Salmi and S. Jalkanen Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans Blood, September 1, 2006; 108(5): 1555 - 1561. [Abstract] [Full Text] [PDF]

				P. H. Yu, L.-X. Lu, H. Fan, M. Kazachkov, Z.-J. Jiang, S. Jalkanen, and C. Stolen Involvement of Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination in Lipopolysaccharide-Induced Pulmonary Inflammation Am. J. Pathol., March 1, 2006; 168(3): 718 - 726. [Abstract] [Full Text] [PDF]

				M. Merinen, H. Irjala, M. Salmi, I. Jaakkola, A. Hanninen, and S. Jalkanen Vascular Adhesion Protein-1 Is Involved in Both Acute and Chronic Inflammation in the Mouse Am. J. Pathol., March 1, 2005; 166(3): 793 - 800. [Abstract] [Full Text] [PDF]

				A. Abella, L. Marti, M. Camps, M. Claret, J. Fernandez-Alvarez, R. Gomis, A. Guma, N. Viguerie, C. Carpene, M. Palacin, et al. Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 Activity Exerts an Antidiabetic Action in Goto-Kakizaki Rats Diabetes, April 1, 2003; 52(4): 1004 - 1013. [Abstract] [Full Text] [PDF]

				M. Salmi, C. Stolen, P. Jousilahti, G. G. Yegutkin, P. Tapanainen, T. Janatuinen, M. Knip, S. Jalkanen, and V. Salomaa Insulin-Regulated Increase of Soluble Vascular Adhesion Protein-1 in Diabetes Am. J. Pathol., December 1, 2002; 161(6): 2255 - 2262. [Abstract] [Full Text] [PDF]

				L. Marti, A. Abella, C. Carpene, M. Palacin, X. Testar, and A. Zorzano Combined Treatment With Benzylamine and Low Dosages of Vanadate Enhances Glucose Tolerance and Reduces Hyperglycemia in Streptozotocin-Induced Diabetic Rats Diabetes, September 1, 2001; 50(9): 2061 - 2068. [Abstract] [Full Text] [PDF]

				N. Morin, J.-M. Lizcano, E. Fontana, L. Marti, F. Smih, P. Rouet, D. Prevot, A. Zorzano, M. Unzeta, and C. Carpene Semicarbazide-Sensitive Amine Oxidase Substrates Stimulate Glucose Transport and Inhibit Lipolysis in Human Adipocytes J. Pharmacol. Exp. Ther., May 1, 2001; 297(2): 563 - 572. [Abstract] [Full Text] [PDF]

				N. Andrés, J. M. Lizcano, M. J. Rodríguez, M. Romera, M. Unzeta, and N. Mahy Tissue Activity and Cellular Localization of Human Semicarbazide-sensitive Amine Oxidase J. Histochem. Cytochem., February 1, 2001; 49(2): 209 - 218. [Abstract] [Full Text]

				T. Martelius, M. Salmi, H. Wu, C. Bruggeman, K. Hockerstedt, S. Jalkanen, and I. Lautenschlager Induction of Vascular Adhesion Protein-1 during Liver Allograft Rejection and Concomitant Cytomegalovirus Infection in Rats Am. J. Pathol., October 1, 2000; 157(4): 1229 - 1237. [Abstract] [Full Text] [PDF]

				J. S. Alexander and D. N. Granger Lymphocyte Trafficking Mediated by Vascular Adhesion Protein-1 : Implications for Immune Targeting and Cardiovascular Disease Circ. Res., June 23, 2000; 86(12): 1190 - 1192. [Full Text] [PDF]